Skip to content

Combination Therapy May Treat Prostate Cancer

Study Shows Increased Survival When Hormone Treatment Is Combined With Radiation
Font Size
A
A
A

Radiation vs. Combination Therapy continued...

The hormone therapy reduces levels of male hormones, called androgens, which trigger the growth of prostate cancer cells.

When the researchers looked more closely at the risk groups, Shipley says, there were some important findings.

"If you looked at the subgroup that was in the low-risk category, there was no apparent benefit to the hormone therapy," he says. "It's safe to say it's hard to suggest these men need this treatment."

Adding the hormone therapy to those at high risk of progression appears beneficial, the researches write. However, they had an increase in deaths from prostate cancer at 10 years. The group that benefits most, Shipley says, is the group at intermediate risk of progression.

Side Effects

More men in the combination group had erectile dysfunction than those in the radiation-only group.

Before the treatment, 48% of those in the combination group and 54% of those in the radiation-only group said they could always or nearly always get an erection.

At the one-year mark, 21% of the combination group and 31% of those in the radiation group said that was still true.

''About half [in the hormone therapy group] got some form of hot flashes, and that can be bothersome," Shipley tells WebMD.

The radiation and the combination treatments are likely to be covered by a patient's insurance, Shipley says.

Second Opinion

The study is an important one, says Stanley Liauw, MD, assistant professor of radiation oncology at the University of Chicago. He has researched combination therapy for high-risk prostate cancer.

He reviewed the study findings for WebMD.

Earlier studies have found benefit for combined treatment for men with locally advanced cancers, he says. But it wasn’t known if the combined therapy could help men with earlier cancers.

The new study is not the only one to address the question, he says. "However, this study is the largest, and with mature follow-up. It shows that four months of hormonal therapy does improve survival for men with intermediate-risk prostate cancer."

The study reinforces the need to individualize treatment, he says.

Today on WebMD

man with doctor
Symptoms, risks, treatments
man coughing
Men shouldn’t ignore
 
prostate cancer cells
What does this diagnosis mean?
doctor and male patient
Is it worth it?
 
cancer fighting foods
SLIDESHOW
15 Cancer Symptoms Men Ignore
FEATURE
 
Prostate Enlarged
VIDEO
Picture Of The Prostate
ANATOMY
 
Prostate Cancer Quiz
QUIZ
screening tests for men
SLIDESHOW
 
Prostate Cancer Symptoms
VIDEO
Vitamin D
SLIDESHOW